The microscopic features seen in each sheep where those of pulmonary arteriopathy with intimal thickening (cellular). The endothelial proliferation highly express VEGF but are negative for HIF-1 and NFKB.Therefore overexpression HIF-1 and NFKB are not important mechanisms in the marked endothelial proliferation seen in these type of PH. EG Barr Fritcher, BR Kipp, RM Root, JM Ihrke, C Reynolds. Mayo Clinic, Rochester, MN. Background: Accurate assignment of HER2/neu status is essential to clinical decision making in the treatment of breast cancer. Immunohistochemistry (IHC) is commonly used assay for evaluation of HER-2/neu status. Despite criteria for interpretation of staining results for HER-2/neu, the determination of staining intensity and the percentage of complete membrane staining is subjective. At our institution, IHC HER2/neu specimens are pre-screened by a cytotechnologist (CT) prior to final determination by a pathologist as a quality assurance procedure. The aim of this project was to evaluate the interobserver reproducibility of HER2/neu analysis among CTs and pathologists. Design: HER2/neu was performed on 4234 paraffin-embedded breast tissue specimens using the DAKO HercepTest™ (DakoCytomation, Carpinteria, CA). One of 9 CTs classified each specimen as 0, 1+, 2+, or 3+ for HER-2/neu protein expression. One of 7 pathologists provided a final classification for each specimen. FISH analysis using PathVysion™ (Abbott Molecular, Inc., Des Plaines, IL) was performed on specimens classified as 2+. Only specimens having a CT score, a pathologist score, and a FISH result (if applicable) were analyzed in this study.
requiring acceptance of less than standard work, work stoppage to fix an error or to return work to the sender. Based on these data, we developed 100 indicators of specific SP defects that could be potentially encountered. These indicators were listed on 9 posters with main categories and clarifying sub-menus for 59 staff to document defects encountered in real-time of routine practice over 2 weeks. Results: Data were collected from January 30-February 10, 2006 comprising 1690 accessioned SP cases. 494 of 1690 cases had defects that were encountered internally within the laboratory. The overall defect frequency was 29.2% (3.3 sigma or 32,479 defects per million opportunties). The majority of defects 441/494 (89%) were encountered in the analytic phase -histology slides (151), accessioning (123), gross exam (99), recuts (66), immuno or special stains (2). 41 (8.3%) defects were derived from providers in the pre-analytic phase who passed the defect onto SP where they were detected and corrected. 12 (2.4%) defects resulted in generation of amended reports. Conclusions: With careful surveillance, we have uncovered a baseline defect rate that is nearly 1 out of 3 cases moving through the SP laboratory. Although alarming, this is not to be misconstrued as a tabulation of defects of a diagnostic nature that would have impacted patient care. Rather, this is a reflection of the amount of waste in the SP system requiring correction with resultant re-work and time delay before an acceptable product could be released. These data confirm that the most common defects and corresponding waste encountered in SP are generated within rather than passed onto the laboratory. Heretofore, this inefficiency was quietly recognized, corrected and passed on within in the supply chain without being made visible as a focus of process improvement activities.
Patient Group
Biopsy Length < 0.5cm 0.5 -< 1.0cm 1.0 -< 1.5cm 1.5 -2.0cm > 2.0cm Non-MM Cases 21% (5/24) 64% (86/135) 89% (117/138) 91% (50/55) 100% (8/8) MM Cases 33% (3/9) 50% (12/24) 68% (25/37) 70% (30/43) 92% (22/24) Table 2 . Adequacy Rate: Percentage of biopsies with at least 4 intact marrow spaces as a function of biopsy length.
In attempt to find ways to improve diagnostic material, this study evaluates the effect of BM biopsy length on adequacy in MM and non-MM patients. Design: 408 consecutive BM biopsies from Institution #1 and 83 consecutive MM BM biopsies from Institution #2 were evaluated for BM biopsy length and number of intact marrow spaces. Length was measured on the microscopic slide, and when multiple fragments were present, a sum of the lengths was calculated. An arbitrary designation of 4 intact BM spaces was used to define the minimum content of an optimal biopsy.
Results:
Institution #1
Institution #2 Non-Myeloma Cases N = 354 N = 490 -Unsatisfactory 18 (5%) 34 (7%) Multiple Myeloma Cases N = 54 N = 1,944 -Unsatisfactory 6 (11%) 279 (14%) Table 1 . Biopsy quality comparison for Institutions #1 and #2. Unsatisfactory is defined as no intact marrow spaces within a trephine biopsy.
Conclusions: Unsatisfactory BM biopsy rates (Table 1) suggest the disease process associated with MM results in a higher incidence of suboptimal biopsies. Biopsy length data (Table 2) shows MM BM biopsies require a longer length to achieve an adequacy rate similar to non-MM BM biopsies. When designating 4 or more intact marrow spaces in a trephine biopsy as the minimal volume for diagnostic adequacy, a total biopsy length of at least 1.0 cm should be sought in non-MM patients and 2.0 cm in MM patients to have a high likelihood (>85%) of a quality biopsy. Achieving these goals may decrease the need for repeat procedures.
Experience with Prostate Needle Biopsies (PNB) in a Specialized
Urologic Pathology Laboratory ("Condo Laboratory") J Furman. Jaime Furrman MD. P.A, San Antonio, TX. Background: New models of practices have appeared in different medical specialties. In pathology, along with traditional private and academic settings, new joint ventures in which physicians groups share in profits for pathology services exist. These types of practices are referred to as "condo laboratories". National pathology associations have expressed concerns about the quality of pathology services provided in these laboratories. The aim of this study was to examine the results of objective parameters for PNB in a "condo laboratory" compared to earlier published data in the pathology literature. Design: This is a retrospective study evaluating the results of prostate carcinoma detection of 12 biopsies obtained by TRUS performed by 40 urologists in five practices during the period from July 2005 to July 2006 evaluated in a specalized urologic pathology lab. The PNB were taken from the peripheral zones of the right and left lobes. The biopsy results were compared to the incidence of Prostatic Carcinoma (PC), High Grade Prostatic Intraepithelial Neoplasia (HGPIN), Acinar Atypia (AA) and Benign. The diagnosis results were also compared to second opinion consultations requested by clinicians/patients and submitted to outside institutions. Results: In this study a total of 2608 cases of PNB and 62,123 slides were examined. The results were the following : 972 PC (37.2%), 398 HGPIN (15.2%), 49 AA (2.0%),1189 benign (45.6%). A total of 110 cases (4.2%) were requested for second opinion. Agreement was seen in 91% of the consultations. Disagreement was seen in 9 cases (9.1%). Of the cases of disagreement 6 cases were cases of HGPI vs benign, 1 was a case of AA vs HGPIN and 2 cases between AA and PC. In these two cases our initial DX of carcinoma were confirmed by a second PNB and a third outside opinion respectively. Our number of carcinomas detected (37.2%) was higher than in most publications, but was similar to studies with 12 PNB, were (38.6%) of patients show PC.Our incidence of AA is lower than 5% reported. HGPIN is higher from the mean of 7.6% published but still within the numbers of 15% and 16% reported by other centers.
Conclusions:
The number of PC, AA and benign DX are in accordance with results in the literature. HGPIN is higher than the mean. A 12 core biopsy strategy for TRUSguided biopsy of the prostate gland improves detection and histologic grading of prostate carcinoma. The parameters did not show marked discrepancies between the condo lab and other institutions. There is agreement on most of the second opinions. DM Grzybicki, C Jensen, KR Geisinger, JE Janosky, EM Wojcik, CH Stone, CN Booth, G Carter, FA Meier, RJ Zarbo, SS Raab . University of Pittsburgh, Pittsburgh, PA; University of Iowa, Iowa City, IA; Wake Forest University, Winston-Salem, NC; Loyola University, Maywood, IL; Henry Ford Health System, Detroit, MI. Background: Interpretive variability is substantial for Pap test and histopathologic cervical specimens, and lack of agreement and standardization results in diagnostic errors and over and under treatment. Our goal was to determine the efficacy of specific interventions in improving interpretive reproducibility in cytotechnologists and pathologists. Design: A total of 38 cytotechnologists and 52 pathologists from 5 labs established baseline reproducibility in interpreting Pap test and cervical biopsy specimens, performed interventions to improve, and then re-measured reproducibility using standardized slide study sets. Interventions were lab-specific, interactive and noninteractive, varying from one-on-one discussions and multi-head microscope conferences to didactic lectures. Interactiveness of individual interventions was graded on a 1 to 8 scale. We measured the differences between pre and post-intervention κ for pairwise agreement of lab cytotechnologists, cytologists, and surgical pathologists. Results: Individual lab cytotechnologist, cytopathologist, and surgical pathologist pre and post-intervention site specific median κ values were 0.52 and 0.58, 0.52 and 0.46, and 0.53 and 0.48 respectively. The number of labs that showed post-intervention improvement in cytotechnologist, cytopathologist, and surgical pathologist agreement was 4, 1, and 1, respectively. Lab cytotechnologists who improved their interpretive reproducibility used interactive interventions (> score 3), and non-interactive interventions either resulted in lower or no change in interpretive reproducibility. Many surgical pathologists strongly resisted reproducibility evaluation. Conclusions: Interpretive reproducibility of cervical specimen diagnoses may be improved, and improvement necessitates interactive interventions that appear to be more acceptable to cytotechnologists than pathologists. Current pathologist culture is a major barrier to designing and implementing effective interventions to improve interpretive reproducibility. A recent study looked at the ability of a group of breast pathology experts to reach a consensus on CCLs with atypia. How pathologists in the real world do is not known. We studied a group of pathology trainees as a model for the impact of a training tutorial on the ability to distinguish various types of CCLs. Design: Twenty-four slides including lesions of columnar cell change (8 slides), columnar cell hyperplasia (8 slides) and CCLs with atypia (8 slides) were prepared and reviewed by two senior pathologists (JYR and MRS). Fourteen residents and fellows reviewed these slides at a multiheaded microscope before and after a training tutorial on the criteria of three CCLs. The criteria for the CCLs are summarized in Table 1 .
Improving Interobserver Reproducibility in Pap Test and Cervical Biopsy Interpretations

Results:
The agreement on columnar cell change, hyperplasia, and atypia was 71.1%, 60.7%, 58.9% and 79.4%, 51.8%, 71.3%, before and after a training tutorial respectively. The agreement of columnar cell lesions was 64.6% and 67.3% before and after the training tutorial with minimal increase of agreement after tutorial. The agreement (more than 70% agreement) on individual cases of CCLs is summarized in Table 2 . Conclusions: The recognition of columnar cell lesions can be challenging, The initial agreement among pathology trainees was not high with only 58.9% in CCLs with atypia. Appropriate turorial training can increase the recognition of columnar cell lesions agreement among the pathology trainees and presumably pathologists in practice. Background: Faculty development programs in academic medicine often declare that mentoring is critical for success. Mentoring programs described in the literature do not usually address the needs and expectations of the faculty in planning the initial program. This study utilized a survey to assess attitudes about mentoring at both junior and senior levels, in a large academically oriented group pathology practice, in preparation for designing a structured mentoring program. Design: The survey instrument included 29 items related to mentoring. Questions about attitudes included whether mentoring is important to career development and in what specific areas a mentor should help a mentee. The respondents were also asked about areas in which they would like professional development training. The results were tabulated and analyzed. All 25 anatomic pathology faculty were given the opportunity to participate in this entirely anonymous survey.
The return was 80% for the survey (20/25). 50% of respondents had less than 10 years of faculty experience. 89% believed that mentoring is important in the early career. The majority indicated that mentors should assist the mentee with the following: assessing strengths and weaknesses (95%), guiding career choices (95%), providing mentees with opportunities (100%), facilitating networking (100%), helping with writing grants and papers (84%), advocating on the mentee's behalf (100%), reviewing the mentee's progress (94%), helping mentee set goals (100%), helping mentee prepare performance reviews (89% for all gynecologic pathology cases with IOC. Two gynecologic pathologists validated the data and entered it in a database with special emphasis on IOC accuracy and the incidence of adverse events (AEs).
Results: A total of 731 IOCs were identified, rendered for 662 patients (average 1.2 per patient). Of the 339 IOCs rendered by gynecologic pathologists, 304 (89.7%) were concordant with the final diagnosis, 34 were discordant and 1 case was deferred. The general pathologists were consulted 392 times where the IOC was concordant with the final diagnosis 341 times (87.0%), discordant 48 times and was deferred 3 times. The difference of the concordance rate between the two groups was not statistically significant by Chi-square test (p = 0.394). Discordance in the gynecologic pathologists group was interpretational in 18 and due to sampling in 16 incidents. In the general pathologists group it occurred in 27 and 21 incidents respectively. The difference in the likelihood for interpretational errors between the two groups was not statistically significant by Chi-square test (p = 0.766). Of the 731 IOCs, AEs occurred in 14 cases (1.9%) 2 were given by gynecologic pathologists and 12 by general pathologists. Conclusions: IOC rendered by the pathologists dependent on the areas of their subspecialization in the gynecologic pathology model provides a safer practice. Although the overall accuracy rates are higher when a subspecialist renders the IOC, the differences with that of the generalist's was not statistically significant. More importantly is that the AE rate is significantly lower when subspecialists handle the IOC. In order to evaluate the effectiveness of these guidelines, we analyzed retrospectively all kidney biopsies received over a six-month period, which represents 695 of a total of 26,385 general surgical pathology cases. Results: Of the 695 kidney biopsy results, 218 cases (31.4%) required urgent notification, and 148 cases (67.9%) were communicated to the treating physicians within 24 hours based on the findings of the light and immunofluorescence microscopy. The remaining biopsy results were communicated after critical information of the electron microscopy findings were available, usually within 72 hours. The more common diagnoses that were considered justified for immediate notification are listed in the table below.
Evaluation of Critical Diagnoses in Kidney Pathology
Conclusions: Many critical diagnoses in renal pathology require immediate communication with the attending nephrologists. We propose additional diagnoses in the guidelines set forth by ADASP in the hope to improve patient care and safety. We suggest the list of critical diagnoses should be customized in accordance with the need of and in consultation with the practicing nephrologists within any given institution. The frequency of DIHC use was hospital and practice type dependent (P < 0.001) with academic and community hospitals ordering DIHC in 10.4% and 2.0% of cases, respectively. DIHC ordering within these groups was highly variable with one academic hospital ordering DIHC in 18.5% of cases and several community hospitals ordering DIHC similarly to academic hospitals. The mean number of stains per case was variable across academic hospitals (range: 2.7 to 5.8 stains) and community hospitals (range: 0 to 11.9 stains) (P < 0.001). The hospital frequency of DIHC use correlated with malignancy frequency and case mix; however case mix and/or malignancy frequency could not fully account for variable interinstitutional ordering patterns. For example, academic and community hospitals ordered DIHC in 29% and 19% of prostate needle biopsy cases (P < 0.001) respectively, even though the proportion of malignant cases was similar. Pathology groups ordered different DIHC panels for the same scenario; for example, to diagnose metastatic melanoma, one hospital ordered AE1/3, S100 and HMB45 and a second hospital ordered MelanA and S100. Conclusions: We found high variation in DIHC ordering practices across a diverse group of hospitals in the same medical system. This variability indicates a lack of standardization and suggests the existence of suboptimal use in a yet undetermined portion of cases. Background: Resection of pancreatic tumors is usually planned based on clinical judgment and imaging findings with a diminishing role for a preoperative biopsy. It is a major procedure during which a pathologist is consulted without having a prior tissue diagnosis that could be used as a reference. We summarize our experience at a tertiary care hospital with emphasis on accuracy and confidence level. Design: Surgical pathology database and medical records were searched in the period of 1990 -2005 for all cases with pancreatic diseases. Only data related to surgeries performed for pancreatic tumors were collected. The subgroup of patients who had IOC requested was further analyzed. Results: IOC was requested in 141 of 183 (77%) patients. It was concordant with the final diagnosis in 127 cases (90.1 %) and discordant in 14 cases (9.9 %). In 3 cases, the status of the margins was overcalled resulting in excision of additional tissue. Overcalling of tissue diagnosis occurred in 2 cases and that of extra pancreatic spread in 1 case; all three cases were adequately managed due to the surgeon's clinical judgment. In 4 pancreatic adenocarcinomas, the status of the margins was undercalled with subsequent recurrence in 1-4 months and patients' death in 5-12 months. In one patient with endocrine tumor the surgical margin was undercalled but the patient is alive and well 120 months postoperatively. Undercalling of tissue diagnosis occurred in 2 cases that were nevertheless surgically unresectable. Extra pancreatic spread was undercalled in one patient whose tumor recurred in 3 months. The rendered IOC was definitive in 123 cases (87.2 %), non-definitive in 17 cases (12.1 %) ("favoring" one diagnosis in 9 and using the word "suspicious" in 8), and was deferred in 1 case (0.7 %). In cases with non-definitive IOC, surgeons based their subsequent decisions on the rendered diagnosis disregarding the word "favor" or "suspicious" in 13 cases while they considered the given disclaimer in 4 cases where additional samples were submitted to reach a definitive diagnosis. Conclusions: In our hospital, IOC has a 90.1 % accuracy rate. A false positive reporting of the surgical margin did not significantly impact outcome while the false negative reporting of the surgical margin or extra pancreatic spread had grave consequences. When circumspect terminology is used in reporting frozen section diagnoses, surgeons are likely to proceed based on the rendered diagnosis disregarding its disclaimer. The most common first choice fellowship was general surgical pathology (26%), followed by cytopathology (16%), hematopathology (15%), gastrointestinal pathology (10%), dermatopathology (8%), and forensics (5%). Respondents indicated the most important reasons for pursuing a fellowship included development of expertise (93%), job connections and networking opportunities (55%), and working with known experts (49%). The least important factors were research and publishing opportunities (9%) and experience in practice management (10%) and frozen section (13%). Residents reported that they obtain most information about fellowship programs from the internet; the most important sources were program web sites (70%) and the ACGME web site (43%).
Fellowship Trends in Pathology Residents
Conclusions:
Understanding resident attitudes and expectations will help to maximize quality of post-residency training. The vast majority of residents are planning to pursue at least one fellowship, either in boarded subspecialties (54%), general surgical pathology (26%), or non-boarded subspecialties (15%). The most common reason for pursuing fellowship training was to gain expertise, and the least common was research. Interestingly, most applicants get their information from program web sites, suggesting that up-to-date web sites will be an important recruiting tool for fellowship programs. Results: Of the 100 cases, there was 91% agreement for both ER and PR. 21 and 27 cases were negative for ER and PR, respectively for both observers. There were a total of 18 discrepancies. For ER: 4 cases were negative by GP but positive by the EP. Three focal positive cases by GP were positive by EP. Thus, there were 6 cases with discordance between positive and negative for the GP and EP. For PR, there was 96% concordance between positive and negative. Three cases were negative by GP but positive by the EP and 1 case was negative by GP and positive by the EP. Five focal positive cases by GP were positive by EP.
Immunohistochemical Analysis of Estrogen (ER) and
Conclusions:
Concordance between GP and EP was 94% and 96%, respectively for ER and PR. For both ER and PR similar rates of discordance between negative by GP and positive by EP were observed (4 and 3%) as well as focal positive by GP and positive by EP (3 and 5%). Although subjective interpretation and technical variations may limit the ability for widespread accurate quantitation in an inherently qualitative test, our results show a high concordance rate between GP and EP. However, discrepancies of 4-6% may yet have significant clinical impact on patient treatment and therefore survival. Thus, these results may not be acceptable for a diagnostic IHC test that determines therapy. A major diagnostic disagreement was defined as a discordant diagnosis with potential for significant change in treatment or prognosis. Major diagnostic disagreements were classified into organ systems and also according to the clinical significance of the changed diagnosis based upon follow-up chart review. Results: Of the 3410 cases reviewed, second opinion surgical pathology resulted in 84 (2.5%) major diagnostic disagreements and 275 (8.1%) cases with minor diagnostic disagreements. 24 (28.6%) of the cases with major disagreements were from the female reproductive tract, 17 (21.4%) were from the gastrointestinal tract, 17 (20.2%) were skin cases, 9 (10.7%) were from the head and neck, 5 (6.0%) were prostate cases, 4 (4.7%) were from the kidney or bladder, and the remaining 7 were from breast (3), lymph nodes (2), muscle (1), and soft tissue (1). Of the 84 cases with major diagnostic disagreements, 45 (1.3% of total cases reviewed) prompted changes in the clinical management and therapy as a result of the second opinion diagnosis. Conclusions: Mandatory second opinion identified clinically significant discrepancies in a small percentage of general surgical pathology cases, however over 50% of these changed diagnoses significantly altered clinical management. These findings support the idea that mandatory second opinion is a useful quality assurance tool in the referral setting.
A Comparison of Sampling Techniques in the Pathological Staging of 222 Radical Prostatectomy Specimens RL Matthews, M Kida, K Cooper. UVM-FAHC, Burlington, VT.
Background: The current lack of standardized processing in the evaluation of radical prostatectomy specimens has resulted in a wide variation of submission protocols. Some institutions choose to submit representative sections (RS), including apex, base of the seminal vesicles and proximal and distal margins. According to the ASCP, only 12% of laboratories surveyed submit the entire specimen (ES) for microscopic examination. In an era of limited healthcare resources, the goal is clearly to obtain diagnostic accuracy using the fewest number of blocks. We compare the efficacy of these two sampling methods in detecting diagnostic and prognostic factors. Design: A total of 222 radical prostatectomy specimens diagnosed as adenocarcinoma were processed at our institution from 2001-2006. Since 2004, our department has submitted 110 consecutive ES cases. A CoPath database search identified a matching number of RS cases. We reviewed the surgical pathology reports for diagnostic and prognostic factors that directly affect staging and clinical management, including capsular penetration, positive margins, PIN, and lymphovascular and perineural invasion.
Results:
The patients ranged from 40 to 78 years of age (mean 60y). The prostate specimens ranged from 15.5 to 150 grams (mean 43g). Of the 112 RS cases (mean 20 blocks), 21% showed extraprostatic extension, 43% had positive surgical margins, 79% demonstrated perineural invasion, and 2% showed lymphovascular invasion. Of the 110 ES cases (mean 39 blocks), 40% showed extraprostatic extension, 36% had positive surgical margins, 82% demonstrated perineural invasion, and 8% showed lymphovascular invasion. PIN was identified in 99% of ES cases, compared with 85% of RS cases. The mean total Gleason score (6.92 ES, 6.95 RS) was nearly identical in the two groups. Conclusions: Clinicians depend on the pathology report for accurate diagnosis and staging, which guide them in determining appropriate treatment recommendations. Thus, uniformity in specimen processing and reporting is essential. We found that complete submission of the prostate gland in radical prostatectomy specimens identified extraprostatic tumor spread twice as often when compared with cases evaluated by representative sampling (40% ES, 21% RS), a finding that escalates the tumor stage from pT2 to pT3 (AJCC) and may prompt neoadjuvant therapy. We feel that a larger study is warranted and that entire submission of the gland may be appropriate for accurate reporting of adenocarcinoma of the prostate. Background: Previous classifications of pathology errors have been incomplete, inconsistent and institution-specific. In this study, we validate across several institutions a classification of defects found in amended pathology reports and in cytologicalhistological (CH) non-correlations. Design: A four-part classification of 1-mis-identification, 2-specimen defects, 3-misinterpretation, and 4-report defects was developed by studying cases of pathology report emendation and its reproducibility previously confirmed within a single institution. Next, the taxonomy was applied to a second genre of pathology defects (CH non-correlation) and a fifth category (indeterminate discrepancy) was added. Finally, 15 defects causing amended reports and 15 instances of apparent CH non-correlation were assembled from the case files of 2 institutions, de-identified, and circulated to pathologists at 7
institutions. The kappa statistic assessed the degree to which the pathologists agreed in their classifications. Disagreements in classifications were discussed. A second panel of 30 cases, half occurring in report emendation and half CH non-correlation, was subjected to a second classification effort and kappa assessement. The agreement did not change with the inter-scrutiny intervention, but the range of interobserver variation was wider in the second, compared to the first scrutiny. Individual observer pairs also reviewed remarkably consistently across the two classification events, but pairs with the highest agreement at the initial event, in general, regressed toward the mean in the second event, while those with the worst initial agreement further deteriorated; those with moderate agreement generally improved.
Conclusions:
If one rates kappa values of 0-2 as 'poor' 2-4 'fair', 4-6 'moderate', 6-8 'good' and 8-10 'excellent', then the inter-institutional classification agreement demonstrated here is consistently 'good' as applied to two panels of defects, those leading to amended reports and instances of apparent CH non-correlation. The intervention between the 2 classification events of discussion of cases causing dissonance failed to achieve improvement. A pedagogical intervention between the classification events did not significantly affect agreement. Granulomas were present in 66/ 561 benign specimens. All 36 discrepancies in benign FHD were accounted for by granulomas that were missed by IOC cytology and identified during FHD or were misidentified during IOC and were absent in the FHD amounting to 55% (36/66) discrepancy rate. Twenty nine (29) of the 36 specimens had IOC cytology only.
In conclusion, IOC cytology of pulmonary specimens appears to be more suitable in differentiating benign from malignant disease than in its ability to detect granulomas. When an infectious or granulomatous process is suspected, a frozen section may improve the diagnostic accuracy, and help in guiding intraoperative handling of additional specimens for further diagnostic studies.
Retrospective Peer Review of Diagnostic Bladder Biopsies:
Experience within a "Center of Excellence" Model AV Parwani, S Raab, L Mahood, R Dhir. University of Pittsburgh Medical Center, Pittsburgh, PA. Background: In many institutes, all or a subset of cases are reviewed routinely by a second pathologist within the same department as a method of quality assurance. Studies have shown that error rates range from 0.26% to 1.2% for global in-house prospective review and 4.0% for retrospective blinded review. These errors may be major, minor or clerical. The objectives of the current study were to perform a retrospective review of diagnostic bladder biopsies in our clinical practice, which is primarily a subspecialtybased academic setting. Design: The surgical pathology files at our institute were searched for bladder biopsies with a diagnosis of carcinoma in situ (CIS), cystitis with atypia, cystitis with reactive changes or dysplasia for a one-year period. A total of 73 cases matching the search criteria were identified. Out of these, a total of 59 complete cases with 1 to 6 parts were available for review. The slides with final reports and review sheets were distributed to two pathologists with expertise in Genitourinary Pathology. The cases were distributed so that the reviewer was different than the original case pathologist. Results: · Of the 59 cases reviewed, 19 were originally diagnosed as CIS, 34 as cystitis with reactive changes or atypia, and 6 with dysplasia · 56 reviews agreed with the original diagnosis. · 3 reviews were coded as Minor Disagreements (5%). · The Minor Disagreements included: 2 overcalls (CIS to Dysplasia) and 1 under call (Benign, reactive changes to Dysplasia).
Conclusions:
Since we are a subspecialty-based sign out practice, we routinely do not have a second prospective review of cases and the value of this practice is not known. Prior to institution of this focused retrospective review of diagnostic biopsies, all our cases were subjected to a 5% global review by a second pathologist. In the current study, even though no major discrepancies were uncovered, the data indicates that minor disagreements do occur and it may be beneficial to have focused quality assurance studies based on the difficult or controversial areas of the subspecialty. This is particularly important in assessment of grading and staging information.
Types of Frozen Section Errors and Deferal Rates in a SubSpeciality Based Academic Surgical Pathology Practice
AV Parwani, C Vrbin, S Raab. University of Pittsburgh, Pittsburgh, PA. Background: Many surgeons consider intraoperative frozen section examination as an important part of surgery, providing guidance to the surgeon about margin status and/or tumor type. Our hospital network has recently moved towards a speciality-based anatomical pathology signout. The impact of this specialization on frozen section accuracy is not well-characterized. Our overall objective was to quantitate the number and types of errors for a two year period and to examine the percentage of deferred cases annually for each of the sub-specialities. Design: We reviewed the pathology records at our institution for all the frozen section examinations performed in a 2 year period (2004) (2005) . We compared the number and types of discrepancies, including sampling and interpretation errors that occurred over this time period .We also examined the number of cases which were deferred on the basis of sub-specialities. In select cases, the histological slides of the specimens submitted for frozen sections and the corresponding permanent section, were reviewed. Results: Table 1 Conclusions: The overall error rate were 1.2 (sampling) and 1.8 (interpretation), both within the range of previously published error ranges in pathology. The deferrals in some sub-specialities were higher than others, probably related to specimen type. Some innovations have been introduced recently to reduce frozen section discrepancies include imaging the key slides which caused diagnostic difficulty and making them available as teaching tools. Secondly, the Division directors for the various pathology specialities examine the difficult cases and provide constructive feedback to the pathologists involved in the error. The overall goal is to reduce errors and number of deferrals.
The Impact of a Monthly Anatomic Pathology Quality and Safety
Conference on the Pathology Practice TC Pereira, YL Liu, RS Saad, ME Leon, C Pu, KM Jasnosz, PR Olson, G Nathan, KR Fox, JF Silverman. Allegheny General Hospital, Pittsburgh, PA. Background: A monthly Anatomic Pathology (AP) Quality and Safety Conference has been conducted in our department for the past 18 months. The conference is lead by the AP director with presentation of all cases in which there are issues such as amended diagnosis, major diagnostic disagreements, physician complaints, etc. The conference has a case presentation format including brief discussion and review of pertinent literature if necessary, and is attended by all the anatomic pathologists, residents and fellows. Design: An evaluation of the outcomes of the conference was performed by classifying the cases presented into categories of types of problem and further action implemented, and comparing number of cases in each category for two 9-month time-periods during which the conference was held (0-9m, 10-18m).
Results: There were a total of 352 cases in which 167 were reviewed in the first time period and 185 in the second time period. Table 1 shows the issue types per time period  and table 2 shows action implemented. Conclusions: There was marked improvement in the second period time with less cases of incomplete examination, incorrect tumor classification/staging, and other clinically significant incorrect diagnoses. Even though the total number of cases was higher in the second period, these were mostly due to terminology/clerical problems and inadequate/ incomplete report. In many of these cases no further action was implemented, reflecting that the issues were minor. We concluded that the Monthly AP Quality and Safety Conference has not only been a valid educational experience, but has also improved the quality of our pathology practice. Following an implementation period of 3 months, a review was performed on the quality of the slides from cases processed by the rapid tissue processor to determine if the quality of the surgical pathology slides had been impacted by the implementation of the Tissue-Tek® Xpress®. Design: 50 rapidly processed surgical pathology cases were compared to 50 matched cases that had been routinely processed in the same time frame. The quality of processing, cutting and staining and an overall assessment for each case was rated as either poor (1), fair (2) or good (3). The review was performed independently by two staff pathologists who were blinded from the processing method. Cases in which any one of the 4 categories was judged as good by one pathologist and poor by the second underwent a re-review by both pathologists. This final re-review score was used in the final analysis. Conclusions: The quality of cases processed using the Sakura Tissue-Tek® Xpress® rapid tissue processing system appears to be lower than those processed using conventional methods. The decision to implement this rapid processing system should be subject to a trade off of the improved turn-around-time and the reduced quality of the histopathology. Background: Clinical application of cytological screening using the liquid-based technique has gained significant acceptance in recent years. Several independent reports suggest a significant reduction in the rate of unsatisfactory specimens when using the liquid-based technique compared with the conventional one. In January 2004, the Henry Ford Health System implemented an institutional policy of liquid-based cytological screening. By August of that year the policy was fully operational in all HFHS clinics and hospitals. We report the primary findings of an ongoing cost-effective analysis study of this policy. Design: We have implemented a cost-effectiveness study with the objective of comparing the outcome of converting cytological screening from the conventional methods to the liquid-based technique. The outcome is measured in terms of monetary cost per unit of effectiveness. We have defined the monetary cost as the ratio of expenses observed by the laboratory to the charges directed to the patient per month. The unit of effectiveness is defined as the proportion of unsatisfactory specimens to the total specimens processed per month. Administrative cytopathology data, beginning with January 1st, 2002 and ending with June 30th, 2006, were retrieved from the Pathology Information System. Statistical analyses were performed using SAS for window version 9.1 (SAS Institute, Cary, NC).
Results:
The overall monthly rate of specimen evaluation in the cytopathology laboratory at our institution declined by 17.5% (95% CI 3.2%-75.0%) when the technique was converted to the liquid-based method. However, the overall decline in the monthly rate of unsatisfactory specimens was 58% (95% CI 25.3%-209.7%). The proportion of unsatisfactory specimens (unit of effectiveness) using the liquid-based technique was approximately 2-fold lower than the conventional method (p <.001). Findings suggest that monetary cost for the two techniques is not statistically significant; however, the difference in the monetary cost per unit of effectiveness is. Conclusions: Preliminary results suggest that the liquid-based screening method offers a cost effective screening method despite its higher laboratory direct operational cost. It is emphasized that we did not include the indirect costs, i.e. ancillary staff's time and resources required for rescheduling of a patient for a second visit, the clinician's time and the patient's time and resources in this preliminary analysis. We implemented a Lean learning line in the histology component of an anatomic pathology lab. After a 3 year period, we measured the metrics of efficiency (turn around time (TAT)), production to staffing ratio, and errors pre and post implementation. We initiated a tracking system that measured 24 separate quality/error metrics (e.g., loss of tissue, poor quality stain). We performed over 200 documented line "experiments" affecting quality and/or error. Each experiment was scored on a 1 to 5 basis (5 being high) for the mean impact (degree of error reduction), success (sustainability and degree of affect on targeted measure), and complexity (scale of intervention). We estimated the degree of error reduction by performing root cause analysis of errors at each step in the histology process and assessing how each initiative affected these errors. Costs were assessed by measuring Medicare technical fees, based on CPT codes, and distributed across the different technical lab components (e.g., gross room, histology, etc.). Results: Although the volume of work increased by 73%, the TAT within the histology component decreased by 42%. The production to staffing ratio, as measured by the specimens of work per day divided by the number of workers, increased from 8.2 to 10.3 (increase of 26%), reflecting an increase in productivity. The increased volume resulted in increased revenue of $125,000 per year attributable solely to the histology lab productivity. Prior to implementation, very few errors were reported and error reporting increased by over 3000%, as the culture of the lab changed from one of fear to ownership. The mean impact, success, and complexity of each experiment was 2.4, 2.7, and 2.5, respectively, although 32%, 26%, and 20%, respectively, had scores greater than 4. We estimated that these experiments reduced the frequency of error by approximately 45%. Error reduction initiatives improved specimen quality and interpretability and drastically reduced the probability of specimen switches.
Conclusions:
The Lean learning line markedly improved efficiency, decreased errors, improved quality, and decreased costs. adenocarcinoma, atypical glandular cells -NOS, atypical glandular cells -endometrial type were also reviewed. In addition, the rate of the unsatisfactory diagnosis was evaluated. Results: Figure 1 demonstrates the change in missing LMP rates by month. Rates of missing LMP were significantly higher during Period 2 (mean=9.2%) when compared to Periods 1 and 3 (means=3.7, 4.5 respectively), (p<0.0001, see Table 1 ). There were no significant differences in diagnostic rates of glandular lesions or unsatisfactory specimens, except adenocarcinoma (p<0.0001). Conclusions: When possible, clinicians would omit additional data entry, such as the LMP, during the office visit, even when the information was considered critical for the specimen submitted. Implementation of the EMR was initally associated with a significant increase in missing clinical information (LMP) in gynecological cytology specimens, and improved compliance was achieved only after it became a required field in the EMR. Background: In spite of technological advances in colposcopic techniques, there continues to be a 10-20% discordance rate between colposcopic findings and the histologic diagnoses of the resultant biopsies. One of the many factors to which this may be attributable is related to sampling error from the paraffin-embedded tissue block. In this study, we evaluated the clinical efficacy of routinely obtaining 6 step sections in cervical biopsies, using the frequency with which dysplastic lesions would be missed with various levels of sectioning as the sole benchmark determinant of clinical efficacy. Design: Our database was searched for all cervical biopsies in which a dysplastic lesion was diagnosed for the period 02/01/06-04/28/06. Six-level step sectioning entails cutting and hematoxylin/eosin-staining 6 consecutive sections from the paraffin block without preserving any intervening unstained sections. The slides were then reviewed by a gynecologic pathologist. The first level at which a dysplastic lesion could be unequivocally diagnosed was determined. Dysplasia grades were also tabulated. Statistical comparisons were carried out with Fisher's Exact and student's t tests, using a p<0.05 threshold for significance. Results: 600 consecutive biopsies from 404 patients were reviewed. For the whole cohort, the average level at which a dysplastic lesion was unequivocally diagnosable was 1.9 (median 1). 357 (59.5%), 97 (16.16%), 41 (6.8%), 55 (9.1%), 34 (5.7%), and 16 (2.7%) of the 600 lesions were diagnosable at levels 1, 2, 3, 4, 5 and 6 respectively. CIN 2/3 (n=89) were on average, diagnosable at an earlier level (1.35) than CIN 1 (n=511): level 2.025 (p<0.001). Indeed, 80% of CIN2/3 were diagnosable at Level 1, as compared with 56% of CIN 1 (p<0.001). 88,38,52,31 and 16 cases of CIN 1 and 10, 3, 3, 2, 0 of CIN 2/3 cases were diagnosable at Levels 2, 3, 4, 5 and 6 respectively. Therefore, if sectioning were limited to 3 levels, 17.3% (104/600) of all dysplastic lesions would have been missed, including 19% (99/511) of CIN 1 and 5.6% (5/89) of CIN2/3. Conclusions: Since only 3 levels are routinely evaluated in most laboratories, our findings suggest that sampling error is indeed at least one significant factor contributing to colposcopic/histologic discrepancies. Using our clinical efficacy standard, in the setting of no pathologic findings of a colposcopic-directed biopsy, at least 5 levels (a priori or in recuts) are required to ensure 100% and 97.4% diagnostic accuracies for CIN 2/3 and CIN 1 respectively.
Statistical Analysis of Surgical Pathology In-House Peer
Consultation in a Large University Hospital Setting G Sharabi. University of Texas Health Science Center, San Antonio, TX. Background: Improving diagnostic accuracy is an aim for every surgical pathologist in practice. Personal consults, sending out cases for expert opinion, and in-house consensus meetings have been established in most big centers to minimize diagnostic errors and to reach an accurate diagnosis in uncommon cases. Sparse statistical data has been published to help predicting the volume and the range of lack of consensus percentages.
